GFG Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

GFG Capital’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$1.05K	–	284
2025 Q2	$1.05K	Buy	+2	New	+$1.12K	﹤0.01%	350
2022 Q1	–	Sell	-595	Closed	-$376K	–	164
2021 Q4	$376K	Buy	595 +32	+6%	+$19.7K	0.11%	95
2021 Q3	$341K	Buy	563 +7	+1%	+$4.35K	0.11%	89
2021 Q2	$311K	Buy	556 +10	+2%	+$5.07K	0.09%	94
2021 Q1	$258K	Sell	546 -580	-52%	-$282K	0.09%	94
2020 Q4	$544K	Buy	1,126 +21	+2%	+$11.3K	0.18%	69
2020 Q3	$619K	Sell	1,105 -8	-0.7%	-$4.85K	0.24%	58
2020 Q2	$694K	Buy	1,113 +38	+4%	+$21.6K	0.3%	49
2020 Q1	$525K	Buy	1,075 +8	+0.7%	+$3.3K	0.27%	45
2019 Q4	$401K	Buy	+1,067	New	+$359K	0.17%	56

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return